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Abstract
The hair follicle is the unique organ that has the capacity of undergoing cyclic 
transformations following periods of growth (anagen), regression (catagen), and 
rest (telogen) regenerating itself to restart the cycle. The dynamic capacity of hair 
to growth and rest enables mammals to control hair growth and length in different 
body side and to change their coats. Unlike what is observed in many animals in 
which the pelage synchronously passes from one phase of the cycle to other all stages 
of growth cycle are simultaneously found in the human pelage, the growth pattern 
is a mosaic where the hair cycling staging of one hair root is completely independent 
of it nearest hair follicle, meaning that each follicular unit (FU) can contain follicles 
in different stages at any given time. A variety of factors, such as nutritional status, 
hormones, exposure to radiations, chemotherapy or radiotherapy, environmental 
pollution or drugs may affect hair growth, and affects the number of hairs, this 
progressive hair loss has a cosmetic and social impact that often significantly affects 
social and psychological well-being of the patient that suffers from this hair loss. 
Although a number of therapies, such as finasteride and minoxidil, are approved 
medications, a wide variety of classes of phytochemicals and natural products, 
including those present in ginseng are being testing. The purpose of this chapter is to 
focus on study the potential of ginseng and its metabolites in hair loss.
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1. Introduction
1.1 Hair structure
Hair is made of several proteins, the principal protein that compound the fibrous 
structure of the hair is keratin, in addition to keratin, which has a high content 
of the amino acid cysteine, the hair also contains water, lipids, minerals, and the 
pigment melanin.
The hair shaft (the visible fiber that is growth above the skin), is a fiber with a 
variety of color depending of the melanin content that pigmented the keratin fiber. 
The dermal element in the hair follicle is the dermal papilla, which is majorly former 
by fibroblast cells, this dermal element controls the hair cycle.
The fiber of the hair, the hair shaft, grows from the hair follicle which is a tubular 
structure that forms a bulb around the matrix of the hair bulb, specialized dermal 
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stem cell and different types of keratinocytes, from this hair bulb that form the der-
mal papilla the hair shaft growth by division of proliferative cells, thus cells goes to a 
process of differentiated, keratinized, and pigmented in the hair follicle to form the 
hair shaft in a cycling manner. The diameter of the hair shaft is directly related to the 
size of the papilla, and allows us to define the miniaturized hairs and normal hair.
The hair structure is composed by concentric layers that forms the hair follicle, 
the medulla which is the center is includes the cortex and outwards the cuticle of the 
cortex, and is surrounded by the inner and outer root sheath, and all the mini-organ 
is surrounded by connective tissue.
1.2 Hair function
The functional aspect of hair is not only to protect from radiation, heat or cold 
and any extern agent but also contribute to the appearance and personality. The loss 
of the hair contributes to psychological, social and psychosocial problems, generat-
ing a cosmetic and social impact in our society.
1.3 Hair cycle
The hair follicle has the unique capacity of undergoing periods of growth (ana-
gen), regression (catagen), and rest (telogen and exogen) before regenerating itself 
to restart the cycle [1–4] (Figure 1). This dynamic cycling capacity enables mammals 
to change their coats, and for hair length to be controlled on different body sites [5].
Unlike what is observed in many animals in which the pelage synchronously 
passes from one phase of the cycle to other all stages of growth cycle are simulta-
neously found in the human, the growth pattern is a mosaic where the hair cycling 
staging of one hair root is completely independent of it nearest hair follicle, 
meaning that each follicular unit (FU) can contain follicles in different stages at 
any given time. In healthy individuals, 80–90% of follicles are in the anagen phase, 
1–2% in the catagen phase, and 10–15% in the telogen phase [6]. The hair grows 
around one centimeter a month, and has a variable growth speed being faster in 
the summer than in winter. The growth phase, or anagen phase, lasts an average 
of 3–5 years. This normal hair-growth cycle can be modified or by internal or 
external factors such as hormones, stress, sun, disease, exposure to environmental 
pollution, drugs and smoking. This changes in the growth cycle and quality of hair 
can leads to hair loss by a shortening of the anagen phase, a premature ingression 
of the catagen phase, the prolongation of the telogen phase or a loss of the hair 
Figure 1. 
Hair cycle stages scheme, phase of growth (anagen), regression (catagen), and rest (telogen) before regenerating 
itself to restart the cycle.
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follicle function [6, 7]. Common hair loss is medically named as alopecia, and can 
be suffer by men and women.
1.4 Hair loss
Research has shown that in hair loss, the percentage of telogen follicles is 
increased, while the percentage of anagen and catagen follicles is reduced. A healthy 
individual loses approximately 100–150 hairs per day [6]. Cell-signaling pathways in 
hair follicular cells resulting in the induction of apoptosis, changes in usual pattern 
of hair cycling, inducing the hair follicle to turn into regression or resting phase and 
thinning or fracture of the hair shaft leads to progressive hair loss and alopecia [7].
Hair loss is a universal problem for numerous people in the world, is a disorder 
in which the hair falls out from skin areas such as scalp, the body and face. Multiples 
factors contribute to hair loss including genetics, hormones, nutritional status, 
and environmental exposure (exposure to radiations, environmental toxicants…), 
medications and nutrition.
Androgenic alopecia can be suffered by women and men and the androgens 
hormones are the most important of the factors that cause the hair lost patron char-
acterized by a miniaturized of the hair follicles that leads to hair lost in the frontal to 
parietal area.
Other forms of hair loss are for example caused by immunogenic hair loss, like 
alopecia areata, this is characterized by a spot of hair lost all around the scalp. The 
approved therapies such as finasteride and minoxidil, are the traditional medication 
used for this hair lost diseases, a few others are in progress, like a wide variety of diverse 
phytochemicals, including those present in ginseng, the ginsenosides which have dem-
onstrated hair growth-promoting effects in a large number of preclinical studies [7].
Androgenic baldness (androgenic alopecia) and circular/spot baldness (alopecia 
areata) are the most common forms of hair loss. The first is characterized by high 
sensitivity of the hair follicles to DH, while the second is induced by an autoimmune 
reaction [8, 9]. Hair also possesses its own immune system, the failure of which can 
lead to spot baldness (alopecia areata).
Alopecia is extended all round the world, reaching nowadays approximately to 10 
million patients suffering from alopecia. Considering the pathological background of 
alopecia and its impact on an individual’s health and social value, there is now a grow-
ing interest in the development of novel therapeutics for its medical management [7].
1.5 Conventional treatment for hair lost
Given the negative psychosocial impact of hair loss, patients follow different 
therapies, conventional treatments such as the two medications approved by the 
United States Food and Drug Administration (US-FDA): Minoxidil and Finasteride, 
for the treatment of alopecia.
Finasteride has a potent effect against androgens, being non-steroidal, it has 
shown to prevent male and female hair loss through the inhibition of type II 
5α-reductase, which affects androgen metabolism avoiding the conversion of free 
testosterone into 5α-dihydrotestosterone, playing an important role in the patho-
genesis of androgenetic alopecia in men and women [10].
The effect of minoxidil as hair growth stimulating has been known over last 
decades, since it was introduced in the early 1970 as a treatment for hypertension. But 
yet the basic mechanism of action on the hair follicle is not clearly understood [11, 12].
These drugs work improving the quality of the hair follicles and reducing the hair 
lost but exhibit certain adverse effects, such as allergic contact dermatitis, erythema, 
and itching, and also stop recommended guideline of minoxidil leads to recurrence 
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of alopecia and a prolonged use of finasteride causes male sexual dysfunction and 
appears as a major cause of infertility and teratogenicity in females.
Patient that do not see significant hair restoration with conventional therapies 
or suffer side effects often change from these conventional treatments to alternative 
medicine trying new treatments from the vast resources of natural products, in an 
attempt to find safe, natural and efficacious therapies to restore the hair.
2. Natural products
Natural products as it is known in the market “Dietary supplements” includes 
diverse subgroups like vitamins, probiotics, minerals, herbs, extracts, gels that do 
not require Food and Drug Administration (FDA) approval [13].
To treat hair loss are available treatments using amino acids, caffeine, capsa-
icin, curcumin, garlic gel, onion gel and extract, cinnamon, Aloe Vera gel, marine 
proteins, melatonin, procyanidin, pumpkin seed oil, rosemary oil, saw palmetto, 
vitamin B7 (biotin), vitamin D, vitamin E, zinc and Ginseng [9, 13].
3. Ginseng
Ginseng is an ancient herbal remedy that was recorded in The Herbal Classic of 
the Divine Plowman, the oldest comprehensive Materia Medica, which was scripted 
approximately 2000 years ago [9].
Among different species which are known as ginseng, Panax ginseng (Korean 
or Asian red ginseng) is the most frequently used one. The Ginseng is widely 
appreciated because it promotes health effect improving the immune response, 
the cardiovascular system, helping with sexual dysfunctions, preventing  
cancer, inhibiting tumor cell proliferation among others. In Dermatologic dis-
eases, cancer is being investigate for its therapeutic effects in skin wound repara-
tion, reducing immune response in dermatitis, reduces and prevent skin damage 
due to photo aging and cold hypersensitivity, improves hair growth reducing hair 
loss in alopecia [14].
Nowadays has gained fame as one of the most popular herbs originating from 
Eastern Countries, because contemporary science has revealed that ginseng con-
tains a wide variety of bioactive constituents, especially a group of saponin com-
pounds collectively known as ginsenosides, which have been proposed to account 
for most of the diverse biological activities, including the hair-growth potential of 
ginseng [9]. Ginsenosides can be classified, depending on the number of hydroxyl 
groups available for glycosylation via dehydration reactions, as protopanaxadiol 
(PPD) and protopanaxatriol (PPT). Common PPD-type ginsenosides include 
ginsenosides Rb1, Rb2, Rc, Rd., Rg3, F2, Rh2, compound K (cK), and PPD, whereas 
PPT-type ginsenosides include Re, Rf, Rg1, Rg2, F1, Rh1, and PPT [9] and malony 
ginsenosides mRb1, mRb2 and mRbc [15]. Ginseng extract or its specific ginsen-
osides have been tested for their potential to promote hair growth.
3.1 Ginseng biochemical effects on hair growth promotion
The major bioactive constituents of ginseng are ginsenosides and there has 
been evidences suggesting that promote hair growth by enhancing proliferation 
of dermal papilla and preventing hair loss via modulation of various cell-signaling 
pathways [9, 16, 17].
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The role of 5α-reductase enzyme in the hair-loss process has been well-
documented [18], affects androgen metabolism, and it is the pathway how drugs 
approved are used nowadays.
Novel therapeutics ways for the management of hair loss and alopecia improving 
hair-follicle proliferation and reducing hair-loss need new targets (Figure 2). These 
targets include, matrix metalloproteinases (MMPs), extracellular signal-regulated 
protein kinase (ERK), and Janus-activated kinase (JAK), the activation of the pro-
liferation by WNT/Dickkopf homolog 1 (DKK1), sonic hedgehog (Shh), vascular 
endothelial growth factor (VEGF), apoptosis inhibition by transforming growth 
factor-beta (TGF-β).
3.1.1 Photo aging prevention
Photo aging is skin damage induced by radiation exposure (Sun exposure) 
characterized by different inflammatory responses to ultraviolet radiation (UVR). 
Excessive UV irradiation is known to cause skin photo damage by release of oxida-
tive species which leads to skin inflammation, and keratinocyte cell death produc-
ing photo aging and carcinogenesis.
There are evidences that suggest that misbalances in the hair-growth cycle, 
affecting keratinocyte and dermal papilla growth [19] is cause by UVR exposure not 
only producing the damage of the hair shaft as an extracellular tissue, as it is clearly 
evident but also alters the molecular growth [19].
The Reactive Oxidative Species (ROS) accumulation and activation of matrix 
metalloproteinase (MMPs), a tissue-degrading enzymes, produced by UV irradia-
tion compromises dermal and epidermal structural integrity [9].
The inhibitory effect of ginsenosides on UVB-induced activation of MMP2 
suggests the potential of these ginseng saponins in hair-growth regulation [9]. 
Ginsenosides Rb2 [20] and 20 (S) PPD, have been reported to reduce the formation 
of ROS and MMP-2 secretion in cultured human keratinocytes (HaCaT) cells after 
exposure to UVB radiation. Ginsenoside Rg3 20 (S), reduced ROS generation in 
Figure 2. 
The effect of the 5α-reductase enzyme, dihydrotestosterone, and the growth factor TGF-β on hair loss and the 
potential targets of ginseng in hair growth and loss.
Ginseng in Medicine
6
HaCaT cells and human dermal fibroblasts without affecting cell viability. The 20 
(S) Rg3 also attenuated UVB-induced MMP-2 levels in HaCaT cells [21]. Ginsenoside 
Rh2 reduced UVB radiation-induced expression and activity of MMP-2 in HaCaT 
cells, but UVB-induced ROS formation was only suppressed by 20 (S)-Rh2 [22].
Ginsenosides extracts from the Ginseng radix have shown attenuates radiation-
induced cell death in the skin, improving hair growth. Ki67 positive number of cells 
and Bcl2 protein expression, an antiapoptotic protein, are induced by Total-root 
saponins and ginsenoside Rb1 diminishing apoptotic cells in UVB-exposed human 
keratinocytes [9, 23]. Ginsenoside F1, an enzymatically modified derivative of 
ginsenoside Rg1, by maintaining a constant level of the antiapoptotic protein Bcl-2 
expression in UVB-irradiated HaCaT cells, protect keratinocytes from radiation-
induced apoptosis [9, 24].
3.1.2 Ginsenosides reduces skin aging
Skin aging is a multifactorial process consisting of two distinct and independent 
mechanisms: intrinsic and extrinsic aging.
Ginsenosides, extracted from Ginseng have been tested in several studies in 
antiaging [25, 26]. This antiaging effects, of ginseng extract and ginsenosides is 
produced by maintaining skin structural integrity and regulating hair-growth by 
stimulating wound healing cells, collagen and hyaluronic acid.
Lee et all incubates fibroblasts, which are key wound-healing cells, with Panax 
ginseng, and found that P. ginseng stimulated human dermal fibroblast proliferation 
and collagen synthesis [27]. Human dermal fibroblast have different functions 
and are classified as key wound-healing cells because their function includes the 
production of collagen, growth factors, antioxidants and a balance of matrix-
producing proteins and protease enzymes. In the Human fibroblast P. ginseng root 
extract activates human collagen A2 promotes and induces type-1 pro-collagen via 
phosphorylation of Smad2 [28].
Wrinkle formation, is associated as marker of dermal aging and present a reduced 
level of hyaluronan in the dermis [29]. On HaCaT cell treated with major ginseng 
metabolite (compound K, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol) 
were report that hyaluronan synthase2 (HAS2) gene is one of the most significantly 
induced genes [30] and also was tested that topical application of compound K on 
mouse skin and shows elevated the expression of hyaluronan synthase-2 [30]. The 
hyaluronan synthase-2 is an enzyme essential to hyaluronan synthesis, hyaluronan is 
a major component of most extracellular matrices that has a structural role in tissues 
architectures and regulates cell adhesion, migration and differentiation.
These antiaging effects of ginseng extracts through Src kinase-dependent 
activation of ERK and AKT/PKB kinases in the dermis and papillary dermis result 
in improved skin health, thereby ensuring hair-follicle health and a regular hair 
cycle [9, 30].
3.1.3 Ginseng on androgen alopecia
The exposure to androgens is the major triggers for hair loss is which in most 
cases is genetically predetermined in androgenic alopecia patients [9, 31, 32].
The androgen that mainly plays a role in altering hair cycling is 
5α-dihydrotestosterone (DHT), which is a metabolite of testosterone. The conver-
sion of testosterone to DHT is mediated by the 5α-reductase (5αR) enzyme in each 
follicle [33, 34] (Figure 2). Treatment with 5α-reductase inhibitors, e.g., finasteride, 
prevents the development of alopecia and increases scalp-hair growth [9].
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Topical application of ginseng extract or ginsenosides was reported to enhance 
hair growth. Rhizomes of P. ginseng (red ginseng) containing a considerable amount 
of ginsenoside Ro, Ro is the predominant ginsenoside in the rhizome showed 
greater dose-dependent inhibitory effects against testosterone 5α-reductase (5αR) 
[35]. Ginsenoside Rg3 (a unique ginsenoside in red ginseng) and Rd. also exhib-
ited similar inhibitory effects against 5αR [36]. Another variety of ginseng, the 
Parribacus japonicas rhizome extract that contains a larger quantity of ginsenoside 
Ro also inhibited 5αR enzyme activity. Topical administration of red-ginseng 
rhizome extracts and ginsenoside Ro onto shaved skin of C57BL/6 mice abrogated 
testosterone-mediated suppression of hair regrowth [36].
Major components of hair regenerative capacity such as linoleic acid (LA) and 
β-sitosterol (SITOS) were significantly restored with Red Ginseng Oil (RGO) after 
testosterone (TES)-induced delay of anagen entry in C57BL/6 mice, also RGO and 
its major components reduced the protein level of TGF-β and enhanced the expres-
sion of anti-apoptotic protein Bcl-2, suggesting that RGO is a potent novel thera-
peutic natural product for treatment of androgenic alopecia [37].
Red Ginseng Extract (RGE) and ginsenosides protect hair matrix keratinocyte 
proliferation against dihydrotestosterone (DHT)-induced suppression and affects 
the expression of androgen receptor.
Moreover, RGE, ginsenoside-Rb1, and ginsenoside-Rg3 at lower levels that 
have been shown to inhibit 5a-reductase [35] inhibit the DHT-induced suppression 
of hair matrix keratinocyte proliferation and the DHT-induced upregulation of 
the mRNA expression of androgen receptor in hDPCs [16].DHT is the product of 
testosterone and does not require the activity of 5a-reductase to affect hair follicles, 
and the inhibitory effect of DHT on hair growth is mediated by the androgen recep-
tor in DPCs [38] These results suggest that red ginseng may promote hair growth in 
humans through the regulation of androgen receptor signaling [16].
3.1.4 Effects of ginsenosides on chemotherapy
Majeed et al. review the recent perspectives of ginseng phytochemicals as 
therapeutics in oncology and explain the chemotherapeutic effect of ginsenoside 
as result of its appetites, ant proliferative, anti-angiogenic, anti-inflammatory 
and anti-oxidant properties [39]. The anticancer effect of ginseng was proven in 
various types of cancer: breast, lung, liver, colon and skin cancer. It increases the 
mitochondrial accumulation of apoptosis protein and down regulate the expression 
of anti-apoptotic protein, reducing cancer development. It also aids in the reduc-
tion of alopecia, fatigue and nausea, the known side effects of chemotherapeutic 
drugs [39].
Alopecia induced by chemotherapy is one of the most distressing side effects 
for patients undergoing chemotherapy. One drug used as chemotherapy is 
Cyclophosphamide (CP), also known as cytophosphane. Cyclophosphamide 
metabolite, 4-hydroperoxycyclophosphamide (4-HC) inhibited human hair 
growth, induced premature catagen development, and inhibited prolifera-
tion and stimulated apoptosis of hair matrix keratinocytes inducing the side 
effect of alopecia. In human hair follicle organ culture model pre-treatment 
with Korean Red Ginseng (KRG) before cyclophosphamide metabolite Dong 
In Keum et all shows that KRG suppress 4-HC-induced inhibition of matrix 
keratinocyte proliferation and stimulation of matrix keratinocyte apoptosis, 
playing a protective effect on 4-HC-induced hair growth inhibition and prema-




3.1.5 Activation of dermal papillary cell proliferation
Different intracellular signaling pathways are involving and plays a critical role 
in stimulating hair growth by promoting dermal papillary-cell proliferation.
Hair growth is promote by Ginsenoside Rg3 upregulating Vascular Endothelial 
Growth Factor (VEGF) expression [36].VEGF is a signaling protein which is released 
from the epithelium and increases the angiogenesis of the hair follicle [9, 40–42]. Was 
also demonstrate by Shin et al. that Rg3 increased the proliferation of human dermal 
papillary cells, associating this proliferation with an upregulation of mRNA expression 
of VEGF also stimulated stem cells by upregulating factor-activating CD34 and CD8 
[36] and promoted hair growth even more than minoxidil in mouse [43] it was conclude 
that Rg3 might increase hair growth through stimulation of hair follicle stem cells [36].
RGE and ginsenoside-Rb1 enhanced the proliferation of hair matrix keratino-
cytes, human hair-follicle dermal papillary cells (hDPCs). Treated hair with RGE or 
ginsenoside-Rb1 exhibited substantial cell proliferation and the associated phos-
phorylation of ERK and AKT [16], it was recently demonstrated that ERK activation 
plays an important role in the proliferation of hDPCs [42] and AKT mediates critical 
signals for cell survival and also regulates the survival of DPCs as an antiapoptotic 
molecule [9, 16, 44] proliferation and the prolongation of the survival in the hDPCs 
by red ginseng may be mediated by the ERK and AKT signaling pathway [9, 16].
Human DPC treatment with Gintonin-enriched fraction (GEF) stimulated vas-
cular endothelial growth factor release. Topical application of GEF and minoxidil 
promoted hair growth in a dose-dependent manner. Histological analysis showed 
that GEF and minoxidil increased the number of hair follicles and hair weight [45].
The Bcl-2 family proteins is notable for their regulation of apoptosis machinery, 
a form of programmed cell death, the member of this family either acts as antiapop-
totic or pro apoptotic in nature. During the hair cycle, the dermal papillary cells 
(DPC) is the only region where Bcl-2 is expressed consistently and is considered to 
resist apoptosis [9, 46–48]. In mice Fructus Panax ginseng extract (FPG) increases 
the expression of Bcl-2 and decreases Bax expression, a pro apoptotic species, in 
cultured DPCs [49]. Parks et all concluded that FPG extract improves the cell prolif-
eration of human DPCs through anti apoptotic activation. Topical administration of 
FPG extract might have hair regeneration activity for the treatment of hair loss [49].
3.1.6  Modulation of Wnt/Dickkopf homolog 1 (DKK1), sonic hedgehog (Shh), 
JAK-STAT3 and TGF-β signaling by ginseng
Shh/Gli and Wnt/β path way and related proteins (Shh (Sonic hedgehog,) 
Smoothened (Smo), β-catenin, Cyclin D1 Cyclin E and Gli1 (glioma-associated 
oncogene homolog)) are associated to hair regeneration, promoting telogen-to-
anagen transition, hair follicle formation and growth. [50–56].
Wingless-type integration-site (WNT) signaling plays a key role in hair-follicle 
development. Activation of WNT signaling is necessary for initiation of follicular 
develop, the blockade of WNT signaling by overexpression of the WNT inhibitor, 
Dickkopf Homolog 1 (DKK1), prevents hair-follicle formation in mice [50] and 
inhibited hair growth [9, 50].
β-catenin signaling is essential for epithelial stem-cell fate since keratinocytes adopt 
an epidermal fate in the absence of β-catenin [51], and this signaling pathway is related 
to WNT [52] affecting hair follicle placodes formation, when β-catenin is mutated dur-
ing embryogenesis, formation of placodes that generate hair follicles is blocked [53].
The role of TGF-β in hair loss has been documented through the study revealing 
that treatment with a TGF-β antagonist can promote hair growth via preventing 
catagen progression [57]. Also through the activation of TGF-β and brain-derived 
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neurotrophic factor (BDNF), it was describe that it was enhanced the transition 
from the anagen to the catagen phase [58].
Since TGF-β1 induces catagen in hair follicles and it is closely related to alopecia 
progression it can be say that acts as a pathogenic mediator of androgenic alopecia 
[57, 59] and red ginseng extract can delay the catagen phase and holds the potential to 
promote hair growth, thought downregulation or inhibition of the TGF-β pathway.
On Young Go Kim investigation was concluded that on ultraviolet B (UVB)-
irradiated skin aging in mice, oral administration of Red Ginseng extract protects 
from skin damage induced by ultraviolet B (UVB)-irradiation, increases of skin 
thickness and pigmentation, reduction of skin elasticity, inhibited the increases of 
epidermis and corium thickness. The administration of Red Ginseng extract exert 
the protective action on UVB-radiation skin aging inhibiting the increase of skin 
TGF-beta1 content induced by UVB irradiation [60].
Furthermore on Zheng Li the hair-growth-promoting effects of Protopanaxatiol 
type ginsenoside Re were associated with the downregulation of TGF-β-pathway-
related genes, which are involved in the control of hair-growth phase-transition-
related signaling pathways [61]. On their study shows that topical administration 
of ginsenoside Re on to the back skin of nude mice for up to 45 days significantly 
increased hair-shaft length and hair existent time, and stimulated hair-shaft elon-
gation in the ex vivo cultures of hair follicles isolated from C57BL/6 mouse [61].
The hyper activation of the c-Jun-N-terminal kinase (JNK) pathway in associate 
with an activation of TGF-β-induced hair loss. Korean red ginseng has been attrib-
uted to exert protective effects onTGF-β-induced hair loss by the inhibition of JNK 
on radiation-induced apoptosis of HaCaT cells [62].
By promoting telogen-to-anagen transition of follicular cells and epidermal 
growth, Shh/Gli regulates hair-follicle development, growth and cycling [54, 
55]. Shh−/− mice develop have abnormal hair follicular cells in the dermal papillae 
and blocking Shh activity mice diminished hair growth, this results indicates the 
importance of Shh signaling in hair-growth promotion [56].
Androgenetic alopecia is related to testosterone (TES)-induced delay of anagen 
phase and hair loss. In C57BL/6 mice Red-ginseng oil (RGO) reversed testosterone-
induced suppression of hair regeneration through early inducing anagen phase by 
up-regulating the expression of Shh/Gliand Wnt/β pathway-related proteins, Shh, 
Smoothened (Smo), β-catenin, Cyclin D1 Cyclin E and Gli1. Additionally, RGO 
reduced the protein level of TGF-β but enhanced the expression of anti-apoptotic 
protein Bcl-2 [37] suggesting that RGO is a potent therapeutic natural product for 
treatment of androgenic alopecia possibly through hair re-growth activity [37].
The signaling pathway and anagen induction effect of ginsenoside F2 were 
investigated and compared with finasteride on the effect of hair growth induction in 
Heon-Sub Shin at all paper [43] where MTT assay results indicated cell proliferation 
in human DPC increased a 30% with ginsenoside F2 treatment compared to finas-
teride [43]. Studding the expression of β-catenin and its transcriptional coactivator 
Lef-1, the Ginsenoside F2 compared to finasteride group, increased the expressions 
while decreased the expression of DKK-1. Tissue histological analysis shows that 
administration of ginsenoside F2 promoted hair growth as compared to finasteride, 
increase in the number of hair follicles, thickness of the epidermis, and follicles 
of the anagen phase [43]. Heon-Sub Shin conclude that ginsenoside F2 might be a 
potential new therapeutic compound for anagen induction and hair growth through 
the Wnt signal pathway [43]. In another study by Matsuda et al., ginsenosides Rg3 
and Rb1 [63] extracted from red ginseng stimulates hair growth activity in an organ 
culture of mouse vibrissa follicles. No detailed explanations are given in this paper 
about the mechanism of hair growth, but the results presented by Matsuda et al. [63] 
indicated that Ginseng Radix possesses hair growth promoting activity.
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Panax ginseng (PG) has diverse pharmacological effects such as anti-aging and 
anti-inflammation it exert this effects thought stimulating the proliferation and 
inhibiting the apoptosis [64]. PG extract treatment affected the expression of 
apoptosis-related genes in HFs, Bcl-2 and Bax, through this regulation reversed the 
effect of DKK-1 on ex vivo human hair organ culture, antagonizes DKK-1-induced 
catagen-like changes [9, 64].
Growth factors and cytokines have been proved to influence hair follicle develop-
ment or cycling [65] overexpression and/or secretion of Cytokines, such as inter-
leukins (ILs) and interferons (IFN), cause skin inflammation, TGF beta 1 partially 
inhibited hair growth and EGF, TNF alpha and IL-1 beta completely abrogated it [66] 
There is an aberrant expression pattern of cytokines in alopecia areata hair follicles.
The presence of CD8+ T cells and NKG2D+ cells around the peri-bulbar area of the 
affected hair follicles [67] and upregulation of several ILs, such as IL-2, IL-7, IL-15, 
and IL-21, and IFN-γ leads to immune activation area where’re main suppressed natu-
ral killer (NK) cells [68] and is defined as immune-tolerated area. Loss of immune 
tolerance [68] or immune activation [67], leads to hair-follicle dystrophy and accelera-
tion of the catagen phase [9] by the activation of a cytotoxic cluster of differentiation 
8-positive (CD8+) and NK group 2D-positive (NKG2D+) T cells. In alopecia Areata 
(AA) are found more CD57 − CD16+ NK cells and there is a association between NK 
cells and the collapse of HF-IP (immune privilege) while normal human scalp skin—
that indeed there is no sign of an NK attack on normal anagen VI HFs [69].
Phosphorylate Stat3 in the Janus Kinase (JAK)/Signal transducer and activa-
tor of transcription-3 (STAT3) pathway regulate the activation of CD8+ and the 
NKG2D+ CD8+ T cells [70]. The inhibition of the upstream pathway JAK appears as 
a plausible target for developing a therapy for hair loss [67]. In fact, a number of JAK 
inhibitors, such as tofacitinib, ruxolitinib, baricitinib, CTP-543, PF-06651600 and 
PF-06700841 are in the progress of developing a therapy for alopecia [71, 72] more 
often in alopecia areata a common form of non-scarring hair loss that usually starts 
abruptly with a very high psychological impact [73], it is a T-cell-mediated disease 
which produces circular patches of non-scarring hair loss and nail dystrophy [72].
Ginsenoside Rk1 inhibited the lipopolysaccharide- stimulated phosphorylation of 
JAK2 and STAT3 in murine macrophage cells [74] and Ginsenoside 20(S)-Rh2 exerts 
anti-cancer activity through targeting IL-6-induced JAK2/STAT3 [75]. Topical appli-
cation of ginsenoside F2 by inhibiting the production of IL-17 and ROS, ameliorated 
dermal inflammation skin [69]. In the pathogenesis of alopecia areata is believed to 
be an imbalance of inflammatory cytokines IL-17. Monoclonal antibodies against 
IL-17A leads to hair regrowth in human volunteers [76]. Treatment with Panax 
ginseng saponins diminished the proliferation and differentiation of Th17 cells and 
decreased IL-17 expression [77]. This regulating IL-17 secretion ginsenosides may 
enhance hair growth in alopecia areata [69, 77]. It would be interesting to investigate 
whether ginsenoside Rk1 or other ginsenosides can target JAK/STAT3 signaling in 
dermal papilla and diminish activation of inflammation and immune cells.
4. Conclusion
Ginseng may be a multipurpose natural medicine with an extended history of 
medical application throughout the globe, particularly in Eastern countries.
The beneficial effects of Ginseng cover a good spectrum from immune to 
cardiovascular, cancer and sexual diseases. New advances in the science leads 
elucidate new pharmacological activity of the ginseng and its ginsenosides. There 
are some studies of the use of Ginseng in dermatology investigating its effects 
from molecular to physiological in a skin cancer, dermatitis, alopecia wound 
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injury and of course hair loss because also ginseng and its ginsenosides regulate 
the expression and activity of major proteins involved in hair-cycling phases, so 
the medical use of ginseng is not only restricted to the improvement of general 
wellness, but also extended to the treatment of organ-specific pathological 
conditions, like hair.
Ginseng and its metabolites are associate with the induction of anagen phase 
preventing hair lost and promoting hair growth although further studies should be 
done to elucidate and clarified the mechanisms by which ginseng and its metabo-
lites regulate human hair health.
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